Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

Novo Nordisk A/S is rated Buy with Wegovy pill seen as a potential catalyst to reignite growth & recapture market share. Read ...

With prices starting at $149 for cash-paying patients, the new Wegovy pill undercuts much of the current market.

These robust surges underscore AbbVie’s ability for swift gains, indicating that upcoming catalysts could propel the stock to ...

Danish firm Novo Nordisk expects India’s obesity therapy market to evolve rapidly, saying its recent Wegovy (injectable ...

Anti-vaccine Health Secretary Robert F. Kennedy Jr. and Agriculture Secretary Brook Rollins unveiled the delayed 2025–2030 ...

The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic ...

Let’s delve into details regarding each of the assessed factors, but prior to that, for a quick background: With a $4.6 Tril ...

Researchers examined the long-term natural history of branch-duct intraductal papillary mucinous neoplasms and sought to identify clinical and radiologic factors linked to developing pancreatic cancer ...

From the King Kong of weight-loss jabs to the Godzilla of the category, the GLP-1 industry is undergoing big changes ...

Eligible customers with insurance can pay as little as $25 for a one-month supply of the drug, while cash-paying options ...

His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity ...